Biotech Leaders Hopefully Willow will do ok for their yeast process. InMed Pharma will be number one for API minor Cannabinoids manufacturing hands down. Next week their quiet period after NASDAQ IPO is over and a major milestone is expect by end of Q1 2021. Check it out. I hope Willow does well too, a great Calgary company.